Non-Autoimmune Hemolytic Anemia with Clostridium Ramosum Bacteremia

por Al-kali, Aref, Oswal, Alok, Tfayli, Arafat
Publicado 2008

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)

por Al-Kali, Aref, Wierda, William, Keating, Michael, O’Brien, Susan
Publicado 2010

The Role of Monoclonal Antibodies in the Management of Leukemia

por Al-Ameri, Ali, Cherry, Mohamad, Al-Kali, Aref, Ferrajoli, Alessandra
Publicado 2010

Competing cell clones in myeloproliferative neoplasm

por Al-Kali, Aref, Verstovsek, Srdan, Kantarjian, Hagop, Luthra, Rajyalakshmi, Cortes, Jorge
Publicado en Blood (2010)

An Erythrocytosis-Associated Mutation in the Zinc Finger of PHD2 Provides Insights into Its Binding of p23

por Song, Daisheng, Guan, Wei, Coon, Lea M, Al-Kali, Aref, Oliveira, Jennifer L, Lee, Frank S
Publicado en Hypoxia (Auckl) (2019)

A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis

por Shen, Na, Yan, Fei, Pang, Jiuxia, Wu, Lai-Chu, Al-Kali, Aref, Litzow, Mark R., Liu, Shujun
Publicado 2014

Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia

por Al-Kali, Aref, Cortes, Jorge, Faderl, Stefan, Jones, Dan, Abril, Caroline, Pierce, Sherry, Brandt, Mark, Kantarjian, Hagop, Ravandi, Farhad
Publicado 2011

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

por Almasri, Jehad, Alkhateeb, Hassan B., Firwana, Belal, Sonbol, Mohamad Bassam, Damlaj, Moussab, Wang, Zhen, Murad, M. Hassan, Al-Kali, Aref
Publicado en Syst Rev (2018)

A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors

por Yan, Fei, Al-Kali, Aref, Zhang, Zijie, Liu, Jun, Pang, Jiuxia, Zhao, Na, He, Chuan, Litzow, Mark R., Liu, Shujun
Publicado en Cell Res (2018)

Current Event-Free Survival After Sequential Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia

por Al-Kali, Aref, Kantarjian, Hagop, Shan, Jianqin, Bassett, Roland, Quintás-Cardama, Alfonso, Borthakur, Gautam, Jabbour, Elias, Verstovsek, Srdan, O’Brien, Susan, Cortes, Jorge
Publicado en Cancer (2010)

Inactivation of receptor tyrosine kinases reverts aberrant DNA methylation in acute myeloid leukemia

por Shen, Na, Yan, Fei, Pang, Jiuxia, Zhao, Na, Gangat, Naseema, Wu, Laichu, Bode, Ann M., Al-Kali, Aref, Litzow, Mark R., Liu, Shujun
Publicado en Clin Cancer Res (2017)

Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients

por Al-Kali, Aref, Konoplev, Sergej, Lin, Erpei, Kadia, Tapan, Faderl, Stefan, Ravandi, Farhad, Ayoubi, Mohamad, Brandt, Mark, Cortes, Jorge E., Kantarjian, Hagop, Borthakur, Gautam
Publicado 2012

Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis

por Yang, Xiaojuan, Pang, Jiuxia, Shen, Na, Yan, Fei, Wu, Lai-Chu, Al-Kali, Aref, Litzow, Mark R., Peng, Yong, Lee, Robert J., Liu, Shujun
Publicado en Oncotarget (2016)

Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology

por Osman, Mazen, Akkus, Zeynettin, Jevremovic, Dragan, Nguyen, Phuong L., Roh, Dana, Al-Kali, Aref, Patnaik, Mrinal M., Nanaa, Ahmad, Rizk, Samia, Salama, Mohamed E.
Publicado en J Clin Med (2021)

Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal orig...

por Patnaik, Mrinal M., Lasho, Terra, Howard, Matthew, Finke, Christy, Ketterling, Rhett L., Al-Kali, Aref, Pardanani, Animesh, Droin, Nathalie, Gangat, Naseema, Tefferi, Ayalew, Solary, Eric
Publicado en Blood Cancer J (2018)

Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS‐CoV‐2 pandemic

por Patnaik, Mrinal M., Lasho, Terra, Padron, Eric, McCullough, Kristen, Al‐kali, Aref, Tefferi, Ayalew, Zeidan, Amer M., Gangat, Naseema, Savona, Michael, Steensma, David P., Solary, Eric
Publicado en Am J Hematol (2020)

One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience

por Tefferi, Ayalew, Lasho, Terra L., Jimma, Thitina, Finke, Christy M., Gangat, Naseema, Vaidya, Rakhee, Begna, Kebede H., Al-Kali, Aref, Ketterling, Rhett P., Hanson, Curtis A., Pardanani, Animesh
Publicado 2012

The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia

por Tibes, Raoul, Al-Kali, Aref, Oliver, Gavin R, Delman, Devora H, Hansen, Nanna, Bhagavatula, Keerthi, Mohan, Jayaram, Rakhshan, Fariborz, Wood, Thomas, Foran, James M., Mesa, Ruben A., Bogenberger, James M.
Publicado en J Hematol Oncol (2015)

Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabine

por Sterner, Rosalie M., Kremer, Kimberly N., Al-Kali, Aref, Patnaik, Mrinal M., Gangat, Naseema, Litzow, Mark R., Kaufmann, Scott H., Westendorf, Jennifer J., van Wijnen, Andre J., Hedin, Karen E.
Publicado en Oncotarget (2017)

Momelotinib therapy for myelofibrosis: a 7-year follow-up

por Tefferi, Ayalew, Barraco, Daniela, Lasho, Terra L., Shah, Sahrish, Begna, Kebede H., Al-Kali, Aref, Hogan, William J., Litzow, Mark R., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh
Publicado en Blood Cancer J (2018)